BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
CYP51
,
cell-cell adhesion
,
Lung cancer
,
Lung
,
Human chorionic gonadotropin
,
Quercetin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
H3 2
Summary
General Info
Curated Studies
Most Correlated Studies
Broad Connectivity Map (CMAP 2.0) compound database
Mesenchymal progenitor cells expressing histone H3.3 (H3F3A) K36M mutation
Treatment of WT or PDE10 KO mice with a selective PDE10 inhibitor
Neuroblastoma BE(2)-C cells treated with BIX 01294
MCF7 cells gene expression after 72hr treatment with 5-Aza-CdR or DZNep
Explore Curated Studies Results
Literature
Most Relevant Literature
Identification of ocular regulatory functions of core histone variant H3.2.
A Novel Antifungal Actinomycete Streptomyces sp. Strain H3-2 Effectively Controls Banana Fusarium Wi…
The CENP-T C-terminus is exclusively proximal to H3.1 and not to H3.2 or H3.3.
Chd5 Regulates MuERV-L/MERVL Expression in Mouse Embryonic Stem Cells Via H3K27me3 Modification and …
H3F3A K27M mutation in pediatric CNS tumors: a marker for diffuse high-grade astrocytomas.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
H3: Healthy Minds, Healthy Children, Healthy Chicago Project Evaluation
Pilot Study of B7-H3 CAR-T in Treating Patients With Recurrent and Refractory Glioblastoma
Enoblituzumab (MGA271) in Children With B7-H3-expressing Solid Tumors
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
Recombinant Influenza Vaccine Containing Different H3 Antigens in Healthy Adults 18 to 30 Years of A…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ